We are live on ! Find out more
CIA

Capital Impact Advisors Portfolio holdings

AUM $247M
1-Year Est. Return 31.15%
This Fund
S&P 500
This Quarter Est. Return
+11.19%
1 Year Est. Return
+31.15%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$292M
AUM Growth
+$21.1M
Cap. Flow
-$146K
Cap. Flow %
-0.05%
Top 10 Hldgs %
19.9%
Holding
125
New
1
Increased
41
Reduced
17
Closed
1

Top Buys

Rank Stock Value
1
KPTI icon
Karyopharm Therapeutics
KPTI
+$1.88M
2
CORT icon
Corcept Therapeutics
CORT
+$497K
3
BOX icon
Box
BOX
+$406K
4
EDIT icon
Editas Medicine
EDIT
+$328K
5
LOXO
Loxo Oncology, Inc
LOXO
+$308K

Top Sells

Rank Stock Value
1
SMCI icon
Super Micro Computer
SMCI
+$1.69M
2
NTRA icon
Natera
NTRA
+$1.15M
3
EPAM icon
EPAM Systems
EPAM
+$996K
4
RNG icon
RingCentral
RNG
+$820K
5
PAYC icon
Paycom
PAYC
+$799K

Sector Composition

Rank Sector Weight
1 Technology 25.08%
2 Healthcare 22.23%
3 Communication Services 12.4%
4 Consumer Discretionary 10.65%
5 Financials 7.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MTH icon
101
Meritage Homes
MTH
$4.58B
$1.61M 0.55%
79,712
– –
LOB icon
102
Live Oak Bancshares
LOB
$1.98B
$1.57M 0.54%
58,412
– –
MDGL icon
103
Madrigal Pharmaceuticals
MDGL
$10.8B
$1.53M 0.52%
7,201
+596
+9% +$150K
CTAS icon
104
Cintas
CTAS
$81.9B
$1.53M 0.52%
30,900
– –
TRUP icon
105
Trupanion
TRUP
$1.07B
$1.51M 0.52%
43,251
-2,336
-5% -$90.2K
TTSH
106
DELISTED
Tile Shop Holdings
TTSH
$1.46M 0.5%
200,289
-24,249
-11% -$193K
ZAYO
107
DELISTED
Zayo Group Holdings, Inc.
ZAYO
$1.44M 0.5%
42,237
– –
TTEC icon
108
TTEC Holdings
TTEC
$121M
$1.44M 0.49%
56,105
+5,661
+11% +$165K
STZ icon
109
Constellation Brands
STZ
$22.2B
$1.43M 0.49%
6,652
– –
ACRS icon
110
Aclaris Therapeutics
ACRS
$726M
$1.39M 0.48%
92,889
+4,473
+5% +$76.7K
URBN icon
111
Urban Outfitters
URBN
$6.35B
$1.37M 0.47%
32,881
– –
NTNX icon
112
Nutanix
NTNX
$16B
$1.36M 0.47%
31,920
-12,074
-27% -$637K
SEIC icon
113
SEI Investments
SEIC
$12.4B
$1.32M 0.45%
21,554
– –
HII icon
114
Huntington Ingalls Industries
HII
$12.9B
$1.29M 0.44%
5,052
– –
JAZZ icon
115
Jazz Pharmaceuticals
JAZZ
$15.9B
$1.28M 0.44%
7,699
– –
ANET icon
116
Arista Networks
ANET
$227B
$1.24M 0.43%
74,928
– –
IONS icon
117
Ionis Pharmaceuticals
IONS
$8.6B
$1.24M 0.42%
23,866
– –
ATHN
118
DELISTED
Athenahealth, Inc.
ATHN
$1.23M 0.42%
9,260
– –
DHR icon
119
Danaher
DHR
$137B
$1.23M 0.42%
12,842
– –
WBA
120
DELISTED
Walgreens Boots Alliance
WBA
$1.21M 0.42%
16,387
– –
MNST icon
121
Monster Beverage
MNST
$94.3B
$1.21M 0.41%
41,438
– –
BF.B icon
122
Brown-Forman Class B
BF.B
$13.2B
$1.2M 0.41%
23,716
– –
KMI icon
123
Kinder Morgan
KMI
$71.7B
$1.06M 0.36%
60,227
– –
EXEL icon
124
Exelixis
EXEL
$13.3B
$765K 0.26%
43,378
– –
SMCI icon
125
Super Micro Computer
SMCI
$18.4B
– –
-709,570
Closed -$1.69M
1 2 3 4
5

Similar funds

AI
AXS Investments Port Chester, New York $248M AUM 15.95% 1-Year Est. Return
AB
ANB Bank Denver, Colorado $247M AUM 19.59% 1-Year Est. Return
PWS
Peloton Wealth Strategists Indianapolis, Indiana $247M AUM 13.57% 1-Year Est. Return
BFM
Blacksheep Fund Management Co. Dublin, Ireland $247M AUM 8.75% 1-Year Est. Return
IFPG
Intrepid Financial Planning Group Carmel, Indiana $248M AUM 19.02% 1-Year Est. Return
SCM
Segra Capital Management Palm Beach, Florida $248M AUM 65.61% 1-Year Est. Return
GWS
Greykasell Wealth Strategies Danville, California $248M AUM 22.08% 1-Year Est. Return
MC
Mount Capital London, United Kingdom $248M AUM 4.81% 1-Year Est. Return

Capital Impact Advisors's Q3 2018 Portfolio in Review

As of Q3 2018, Capital Impact Advisors held 125 positions worth $292M, up 7.8% from $270M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Trading was light in Q3 2018: portfolio turnover was 1.6%. Capital Impact Advisors opened 1 new position and exited 1, leaving the 125-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 25% a quarter earlier, followed by Healthcare and Communication Services.

  • Capital Impact Advisors's largest Q3 2018 buy was Karyopharm Therapeutics: 6,800 shares worth $1.74M.
  • Capital Impact Advisors added most to Corcept Therapeutics in Q3 2018, an estimated $497K increase.
  • Capital Impact Advisors's biggest Q3 2018 reduction was Natera, cutting an estimated $1.15M.
  • Capital Impact Advisors fully exited Super Micro Computer in Q3 2018, selling an estimated $1.69M.
  • Capital Impact Advisors's ten largest holdings make up 20% of its $292M portfolio in Q3 2018.
  • Capital Impact Advisors opened 1 new position and closed 1 in Q3 2018.
  • Capital Impact Advisors's portfolio value rose 7.8% quarter-over-quarter to $292M.

Based on Capital Impact Advisors's 13F filing for Q3 2018, filed 19 Oct 2018.